1,611.00
+12(+0.75%)
Currency In JPY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1658
First IPO Date
February 22, 2010
| Name | Title | Pay | Year Born |
| Shuhei Morita | President, Chief Executive Officer & Director | 0 | 1974 |
| Masayuki Naganawa | Managing Executive Officer & Head of Research and Development | 0 | N/A |
| Mr. Seiichi Inoue | Managing Executive Officer & GM of Corporate Division | 0 | 1958 |
| Takeshi Sato | Managing Executive Officer | 0 | N/A |
| Takanori Kikuchi | Executive Officer & Head of Injection Manufacturing Department | 0 | N/A |
| Mr. Satoshi Suzuki | Executive Vice President, Head of Business Strategy Division & Director | 0 | 1963 |
| Mr. Atsuya Mitsuhashi | Managing Executive Officer & Corporate Planning Department | 0 | 1971 |
| Takahiro Nozaki | Executive Office &,Head of Tablet Manufacturing Department | 0 | N/A |
| Kazuhisa Sakurai | Executive Officer & Head of Quality Assurance Department | 0 | N/A |
| Mr. Toyoyuki Kamide | Vice President, Executive Officer & Director | 0 | 1965 |
Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women; in vitro diagnostics, acute medical care products, and curative medicines; and information regarding pharmaceuticals and health. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.
